Skip to main content
NCBI home page
The Ulster Medical Journal logoLink to The Ulster Medical Journal
. 1986 Oct;55(2):124–130.

Subacute sclerosing panencephalitis in Northern Ireland: twenty years' experience

J I Morrow, K E Dowey, M W Swallow
PMCID: PMC2448355  PMID: 3811010

Abstract

Subacute sclerosing panencephalitis (SSPE) is a rare degenerative disease of the central nervous system that affects primarily children and adolescents. It is a late manifestation of measles virus infection. In a 20-year period (1965-85) there have been 26 cases of SSPE in Northern Ireland, a frequency of approximately one case per 1.2 million population per year. Males were affected more frequently than females. In other parts of the world the incidence of this disease has been dramatically reduced following effective measles immunisation programmes. The vaccination rate in Northern Ireland probably remains too low to have a similar effect.

Full text

PDF
124

Images in this article

128Fig 2
on p.128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellman M. H., Dick G. Register of cases of subacute sclerosing panencephalitis. Br Med J. 1977 Feb 12;1(6058):430–431. doi: 10.1136/bmj.1.6058.430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cobb W. A., Marshall J., Scaravilli F. Long survival in subacute sclerosing panencephalitis. J Neurol Neurosurg Psychiatry. 1984 Feb;47(2):176–183. doi: 10.1136/jnnp.47.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Connolly J. H. Additional data on measles virus antibody and antigen in subacute sclerosing panencephalitis. Neurology. 1968 Jan;18(1 Pt 2):87–90. doi: 10.1212/wnl.18.1_part_2.087. [DOI] [PubMed] [Google Scholar]
  4. Connolly J. H., Allen I. V., Hurwitz L. J., Millar J. H. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet. 1967 Mar 11;1(7489):542–544. doi: 10.1016/s0140-6736(67)92117-4. [DOI] [PubMed] [Google Scholar]
  5. Connolly J. H., Allen I. V., Hurwitz L. J., Millar J. H. Subacute sclerosing panencephalitis. Clinical, pathological, epidemiological, and virological findings in three patients. Q J Med. 1968 Oct;37(148):625–644. [PubMed] [Google Scholar]
  6. Dawson J. R. Cellular Inclusions in Cerebral Lesions of Lethargic Encephalitis. Am J Pathol. 1933 Jan;9(1):7–16.3. [PMC free article] [PubMed] [Google Scholar]
  7. Dyken P. R. Subacute sclerosing panencephalitis. Current status. Neurol Clin. 1985 Feb;3(1):179–196. [PubMed] [Google Scholar]
  8. Gould E. A., Linton P. E. The production of a temperature-sensitive persistent measles virus infection. J Gen Virol. 1975 Jul;28(1):21–28. doi: 10.1099/0022-1317-28-1-21. [DOI] [PubMed] [Google Scholar]
  9. Graves M. C. Subacute sclerosing panencephalitis. Neurol Clin. 1984 May;2(2):267–280. [PubMed] [Google Scholar]
  10. Livni E., Kott E., Danon Y., Kuritzky A., Joshua H. Cell-mediated immunity in subacute sclerosing panencephalitis. Isr J Med Sci. 1976 Oct;12(10):1183–1188. [PubMed] [Google Scholar]
  11. Markand O. N., Panszi J. G. The electroencephalogram in subacute sclerosing panencephalitis. Arch Neurol. 1975 Nov;32(11):719–726. doi: 10.1001/archneur.1975.00490530041002. [DOI] [PubMed] [Google Scholar]
  12. Taylor W. J., DuRant R. H., Dyken P. R. Treatment of subacute sclerosing panencephalitis: an overview. Drug Intell Clin Pharm. 1984 May;18(5):375–381. doi: 10.1177/106002808401800503. [DOI] [PubMed] [Google Scholar]

Articles from The Ulster Medical Journal are provided here courtesy of Ulster Medical Society

RESOURCES